Lomelosia comosa

Lomelosia comosa · Accepted scientific name

Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆

Lomelosia comosa is a botanical species recognized for its diverse profile of bioactive secondary metabolites. The plant is characterized by a rich concentration of chemical compounds, including fatty acids, flavonoids, phenols, and terpenoids. These constituents contribute to the plant's significant pharmacological potential in medicinal research. Specifically, scientific interest has focused on its ability to address complex conditions such as liver diseases. Consequently, it shows great promise as a natural therapeutic agent for managing liver fibrosis.

Quick facts
Synonyms
Trochocephalus Togashianus · Trochocephalus Mansenensis · 29 more
Common names
Not available
Family
Caprifoliaceae
Distribution
Not available
Plant Parts
Not available

Classification

Common Names

Lomelosia comosa is a unique botanical species that holds a specific place in regional flora. In German-speaking areas, this plant is widely recognized by its common name, Japanische Skabiose. This nomenclature highlights its distinct characteristics and helps enthusiasts identify it within various landscapes. Understanding these naming conventions is essential for anyone studying the diverse world of flowering plants. By connecting scientific names to local terms, we can better appreciate the global reach of this species.

Sources: Catalogue of Life (COL)

Synonyms

Lomelosia comosa is a botanical subject characterized by a complex network of taxonomic synonyms. Within scientific literature, this plant is frequently identified by the name Scabiosa comosa. Further variations in classification include its designation as Scabiosa comosa f. albiflora and Scabiosa austromongolica. The species also shares historical links with Scabiosa fischeri and the specific form Scabiosa fischeri f. breviseta. Understanding these overlapping names is essential for accurate identification and study within the genus.

Sources: The World Checklist of Vascular Plants (WCVP)

Taxonomy

Lomelosia comosa belongs to the diverse kingdom Plantae, representing a unique branch of the natural world. Within this vast kingdom, the species is classified under the class Equisetopsida. It further falls into the order Dipsacales, showcasing its specific evolutionary lineage. As a member of the genus Lomelosia, it shares distinct morphological traits with its close relatives. Ultimately, this plant is nested within the Caprifoliaceae family, completing its detailed biological identity.

Rank Classification
Kingdom Plantae
Phylum Streptophyta
Class Equisetopsida
Subclass Magnoliidae
Order Dipsacales
Family Caprifoliaceae
Genus Lomelosia

Sources: The World Checklist of Vascular Plants (WCVP)

Distribution

Geographic Regions

Lomelosia comosa is a plant species primarily distributed throughout the Asia-Temperate region. Its presence is notably widespread across various parts of China, including the North-Central and Southeast territories. The species can also be found in the northern reaches of the continent, specifically within Inner Mongolia and Manchuria. Beyond China, its natural habitat extends into Eastern Asia, where it is documented in Korea. This broad distribution highlights the plant's ability to thrive across diverse temperate landscapes in the region.

Sources: The World Checklist of Vascular Plants (WCVP)

Identification

Biological Activities

Compounds

Conditions

Lomelosia comosa, also identified as Scabiosa comosa, serves as a traditional Mongolian medicine used to treat various liver diseases. Scientific studies demonstrate that this plant is effective in treating hepatic fibrosis by reducing collagen deposition and connective tissue hyperplasia. Research specifically shows that it treats CCl4-induced hepatic fibrosis in rat models by modulating key signaling pathways. The plant's ability to treat liver fibrosis is further supported by its capacity to promote the apoptosis of hepatic stellate cells. Through these mechanisms, Lomelosia comosa acts as a significant therapeutic agent against liver fibrosis and its associated damage.

Preparations

Parts used